Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Cord Blood Stem Cells Market Report 2017

  • QYR1144842
  • 124 Pages
  • April 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
In this report, the United States Cord Blood Stem Cells market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume) , revenue (value) , market share and growth rate of Cord Blood Stem Cells in these regions, from 2012 to 2022 (forecast) .

United States Cord Blood Stem Cells market competition by top manufacturers/players, with Cord Blood Stem Cells sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

3Dmatrix

Aldagen

Angioblast Systems

Athersys

Beike Biotechnology

Biotime

Brainstorm Cell Therapeutics

Caladrius Biosciences

Capricor

Cellerant Therapeutics

Gamida Cell

Globalstem

Hybrid Organ

Intellicell Biosciences

International Stem Cell

Juventas Therapeutics

Mesoblast

Neuralstem

Neurogeneration

Ocata

Osiris Therapeutics

Primegen Biotech

Reneuron Group

Rhinocyte

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

Allogeneic Stem Cell

Autologous Stem Cell

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Cord Blood Stem Cells for each application, including

Autoimmune Diseases

Immunodeficiencies

Malignancies,Caners

Solid Tumors

Others

Table of Contents

United States Cord Blood Stem Cells Market Report 2017

1 Cord Blood Stem Cells Overview

1.1 Product Overview and Scope of Cord Blood Stem Cells

1.2 Classification of Cord Blood Stem Cells by Product Category

1.2.1 United States Cord Blood Stem Cells Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Cord Blood Stem Cells Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Allogeneic Stem Cell

1.2.4 Autologous Stem Cell

1.3 United States Cord Blood Stem Cells Market by Application/End Users

1.3.1 United States Cord Blood Stem Cells Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Autoimmune Diseases

1.3.3 Immunodeficiencies

1.3.4 Malignancies,Caners

1.3.5 Solid Tumors

1.3.6 Others

1.4 United States Cord Blood Stem Cells Market by Region

1.4.1 United States Cord Blood Stem Cells Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Cord Blood Stem Cells Status and Prospect (2012-2022)

1.4.3 Southwest Cord Blood Stem Cells Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Cord Blood Stem Cells Status and Prospect (2012-2022)

1.4.5 New England Cord Blood Stem Cells Status and Prospect (2012-2022)

1.4.6 The South Cord Blood Stem Cells Status and Prospect (2012-2022)

1.4.7 The Midwest Cord Blood Stem Cells Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Cord Blood Stem Cells (2012-2022)

1.5.1 United States Cord Blood Stem Cells Sales and Growth Rate (2012-2022)

1.5.2 United States Cord Blood Stem Cells Revenue and Growth Rate (2012-2022)

2 United States Cord Blood Stem Cells Market Competition by Players/Suppliers

2.1 United States Cord Blood Stem Cells Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Cord Blood Stem Cells Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Cord Blood Stem Cells Average Price by Players/Suppliers (2012-2017)

2.4 United States Cord Blood Stem Cells Market Competitive Situation and Trends

2.4.1 United States Cord Blood Stem Cells Market Concentration Rate

2.4.2 United States Cord Blood Stem Cells Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Cord Blood Stem Cells Manufacturing Base Distribution, Sales Area, Product Type

3 United States Cord Blood Stem Cells Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Cord Blood Stem Cells Sales and Market Share by Region (2012-2017)

3.2 United States Cord Blood Stem Cells Revenue and Market Share by Region (2012-2017)

3.3 United States Cord Blood Stem Cells Price by Region (2012-2017)

4 United States Cord Blood Stem Cells Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Cord Blood Stem Cells Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Cord Blood Stem Cells Revenue and Market Share by Type (2012-2017)

4.3 United States Cord Blood Stem Cells Price by Type (2012-2017)

4.4 United States Cord Blood Stem Cells Sales Growth Rate by Type (2012-2017)

5 United States Cord Blood Stem Cells Sales (Volume) by Application (2012-2017)

5.1 United States Cord Blood Stem Cells Sales and Market Share by Application (2012-2017)

5.2 United States Cord Blood Stem Cells Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Cord Blood Stem Cells Players/Suppliers Profiles and Sales Data

6.1 3Dmatrix

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Cord Blood Stem Cells Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 3Dmatrix Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Aldagen

6.2.2 Cord Blood Stem Cells Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Aldagen Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Angioblast Systems

6.3.2 Cord Blood Stem Cells Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Angioblast Systems Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Athersys

6.4.2 Cord Blood Stem Cells Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Athersys Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Beike Biotechnology

6.5.2 Cord Blood Stem Cells Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Beike Biotechnology Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Biotime

6.6.2 Cord Blood Stem Cells Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Biotime Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Brainstorm Cell Therapeutics

6.7.2 Cord Blood Stem Cells Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Brainstorm Cell Therapeutics Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Caladrius Biosciences

6.8.2 Cord Blood Stem Cells Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Caladrius Biosciences Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Capricor

6.9.2 Cord Blood Stem Cells Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Capricor Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Cellerant Therapeutics

6.10.2 Cord Blood Stem Cells Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Cellerant Therapeutics Cord Blood Stem Cells Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Gamida Cell

6.12 Globalstem

6.13 Hybrid Organ

6.14 Intellicell Biosciences

6.15 International Stem Cell

6.16 Juventas Therapeutics

6.17 Mesoblast

6.18 Neuralstem

6.19 Neurogeneration

6.20 Ocata

6.21 Osiris Therapeutics

6.22 Primegen Biotech

6.23 Reneuron Group

6.24 Rhinocyte

7 Cord Blood Stem Cells Manufacturing Cost Analysis

7.1 Cord Blood Stem Cells Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Cord Blood Stem Cells

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Cord Blood Stem Cells Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Cord Blood Stem Cells Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Cord Blood Stem Cells Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Cord Blood Stem Cells Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Cord Blood Stem Cells Sales Volume Forecast by Type (2017-2022)

11.3 United States Cord Blood Stem Cells Sales Volume Forecast by Application (2017-2022)

11.4 United States Cord Blood Stem Cells Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Cord Blood Stem Cells

Figure United States Cord Blood Stem Cells Market Size (K Units) by Type (2012-2022)

Figure United States Cord Blood Stem Cells Sales Volume Market Share by Type (Product Category) in 2016

Figure Allogeneic Stem Cell Product Picture

Figure Autologous Stem Cell Product Picture

Figure United States Cord Blood Stem Cells Market Size (K Units) by Application (2012-2022)

Figure United States Sales Market Share of Cord Blood Stem Cells by Application in 2016

Figure Autoimmune Diseases Examples

Figure Immunodeficiencies Examples

Figure Malignancies,Caners Examples

Figure Solid Tumors Examples

Figure Others Examples

Figure United States Cord Blood Stem Cells Market Size (Million USD) by Region (2012-2022)

Figure The West Cord Blood Stem Cells Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Cord Blood Stem Cells Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Cord Blood Stem Cells Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Cord Blood Stem Cells Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Cord Blood Stem Cells Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Cord Blood Stem Cells Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Cord Blood Stem Cells Sales (K Units) and Growth Rate (2012-2022)

Figure United States Cord Blood Stem Cells Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Cord Blood Stem Cells Market Major Players Product Sales Volume (K Units) (2012-2017)

Table United States Cord Blood Stem Cells Sales (K Units) of Key Players/Suppliers (2012-2017)

Table United States Cord Blood Stem Cells Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Cord Blood Stem Cells Sales Share by Players/Suppliers

Figure 2017 United States Cord Blood Stem Cells Sales Share by Players/Suppliers

Figure United States Cord Blood Stem Cells Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Cord Blood Stem Cells Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Cord Blood Stem Cells Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Cord Blood Stem Cells Revenue Share by Players/Suppliers

Figure 2017 United States Cord Blood Stem Cells Revenue Share by Players/Suppliers

Table United States Market Cord Blood Stem Cells Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)

Figure United States Market Cord Blood Stem Cells Average Price (USD/Unit) of Key Players/Suppliers in 2016

Figure United States Cord Blood Stem Cells Market Share of Top 3 Players/Suppliers

Figure United States Cord Blood Stem Cells Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Cord Blood Stem Cells Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Cord Blood Stem Cells Product Category

Table United States Cord Blood Stem Cells Sales (K Units) by Region (2012-2017)

Table United States Cord Blood Stem Cells Sales Share by Region (2012-2017)

Figure United States Cord Blood Stem Cells Sales Share by Region (2012-2017)

Figure United States Cord Blood Stem Cells Sales Market Share by Region in 2016

Table United States Cord Blood Stem Cells Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Cord Blood Stem Cells Revenue Share by Region (2012-2017)

Figure United States Cord Blood Stem Cells Revenue Market Share by Region (2012-2017)

Figure United States Cord Blood Stem Cells Revenue Market Share by Region in 2016

Table United States Cord Blood Stem Cells Price (USD/Unit) by Region (2012-2017)

Table United States Cord Blood Stem Cells Sales (K Units) by Type (2012-2017)

Table United States Cord Blood Stem Cells Sales Share by Type (2012-2017)

Figure United States Cord Blood Stem Cells Sales Share by Type (2012-2017)

Figure United States Cord Blood Stem Cells Sales Market Share by Type in 2016

Table United States Cord Blood Stem Cells Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Cord Blood Stem Cells Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Cord Blood Stem Cells by Type (2012-2017)

Figure Revenue Market Share of Cord Blood Stem Cells by Type in 2016

Table United States Cord Blood Stem Cells Price (USD/Unit) by Types (2012-2017)

Figure United States Cord Blood Stem Cells Sales Growth Rate by Type (2012-2017)

Table United States Cord Blood Stem Cells Sales (K Units) by Application (2012-2017)

Table United States Cord Blood Stem Cells Sales Market Share by Application (2012-2017)

Figure United States Cord Blood Stem Cells Sales Market Share by Application (2012-2017)

Figure United States Cord Blood Stem Cells Sales Market Share by Application in 2016

Table United States Cord Blood Stem Cells Sales Growth Rate by Application (2012-2017)

Figure United States Cord Blood Stem Cells Sales Growth Rate by Application (2012-2017)

Table 3Dmatrix Basic Information List

Table 3Dmatrix Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)

Figure 3Dmatrix Cord Blood Stem Cells Sales Growth Rate (2012-2017)

Figure 3Dmatrix Cord Blood Stem Cells Sales Market Share in United States (2012-2017)

Figure 3Dmatrix Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)

Table Aldagen Basic Information List

Table Aldagen Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)

Figure Aldagen Cord Blood Stem Cells Sales Growth Rate (2012-2017)

Figure Aldagen Cord Blood Stem Cells Sales Market Share in United States (2012-2017)

Figure Aldagen Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)

Table Angioblast Systems Basic Information List

Table Angioblast Systems Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)

Figure Angioblast Systems Cord Blood Stem Cells Sales Growth Rate (2012-2017)

Figure Angioblast Systems Cord Blood Stem Cells Sales Market Share in United States (2012-2017)

Figure Angioblast Systems Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)

Table Athersys Basic Information List

Table Athersys Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)

Figure Athersys Cord Blood Stem Cells Sales Growth Rate (2012-2017)

Figure Athersys Cord Blood Stem Cells Sales Market Share in United States (2012-2017)

Figure Athersys Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)

Table Beike Biotechnology Basic Information List

Table Beike Biotechnology Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)

Figure Beike Biotechnology Cord Blood Stem Cells Sales Growth Rate (2012-2017)

Figure Beike Biotechnology Cord Blood Stem Cells Sales Market Share in United States (2012-2017)

Figure Beike Biotechnology Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)

Table Biotime Basic Information List

Table Biotime Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)

Figure Biotime Cord Blood Stem Cells Sales Growth Rate (2012-2017)

Figure Biotime Cord Blood Stem Cells Sales Market Share in United States (2012-2017)

Figure Biotime Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)

Table Brainstorm Cell Therapeutics Basic Information List

Table Brainstorm Cell Therapeutics Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)

Figure Brainstorm Cell Therapeutics Cord Blood Stem Cells Sales Growth Rate (2012-2017)

Figure Brainstorm Cell Therapeutics Cord Blood Stem Cells Sales Market Share in United States (2012-2017)

Figure Brainstorm Cell Therapeutics Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)

Table Caladrius Biosciences Basic Information List

Table Caladrius Biosciences Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)

Figure Caladrius Biosciences Cord Blood Stem Cells Sales Growth Rate (2012-2017)

Figure Caladrius Biosciences Cord Blood Stem Cells Sales Market Share in United States (2012-2017)

Figure Caladrius Biosciences Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)

Table Capricor Basic Information List

Table Capricor Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)

Figure Capricor Cord Blood Stem Cells Sales Growth Rate (2012-2017)

Figure Capricor Cord Blood Stem Cells Sales Market Share in United States (2012-2017)

Figure Capricor Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)

Table Cellerant Therapeutics Basic Information List

Table Cellerant Therapeutics Cord Blood Stem Cells Sales (K Units) , Revenue (Million USD) , Price (USD/Unit) and Gross Margin (2012-2017)

Figure Cellerant Therapeutics Cord Blood Stem Cells Sales Growth Rate (2012-2017)

Figure Cellerant Therapeutics Cord Blood Stem Cells Sales Market Share in United States (2012-2017)

Figure Cellerant Therapeutics Cord Blood Stem Cells Revenue Market Share in United States (2012-2017)

Table Gamida Cell Basic Information List

Table Globalstem Basic Information List

Table Hybrid Organ Basic Information List

Table Intellicell Biosciences Basic Information List

Table International Stem Cell Basic Information List

Table Juventas Therapeutics Basic Information List

Table Mesoblast Basic Information List

Table Neuralstem Basic Information List

Table Neurogeneration Basic Information List

Table Ocata Basic Information List

Table Osiris Therapeutics Basic Information List

Table Primegen Biotech Basic Information List

Table Reneuron Group Basic Information List

Table Rhinocyte Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Cord Blood Stem Cells

Figure Manufacturing Process Analysis of Cord Blood Stem Cells

Figure Cord Blood Stem Cells Industrial Chain Analysis

Table Raw Materials Sources of Cord Blood Stem Cells Major Players/Suppliers in 2016

Table Major Buyers of Cord Blood Stem Cells

Table Distributors/Traders List

Figure United States Cord Blood Stem Cells Sales Volume (K Units) and Growth Rate Forecast (2017-2022)

Figure United States Cord Blood Stem Cells Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Cord Blood Stem Cells Price (USD/Unit) Trend Forecast (2017-2022)

Table United States Cord Blood Stem Cells Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Cord Blood Stem Cells Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Cord Blood Stem Cells Sales Volume (K Units) Forecast by Type in 2022

Table United States Cord Blood Stem Cells Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Cord Blood Stem Cells Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Cord Blood Stem Cells Sales Volume (K Units) Forecast by Application in 2022

Table United States Cord Blood Stem Cells Sales Volume (K Units) Forecast by Region (2017-2022)

Table United States Cord Blood Stem Cells Sales Volume Share Forecast by Region (2017-2022)

Figure United States Cord Blood Stem Cells Sales Volume Share Forecast by Region (2017-2022)

Figure United States Cord Blood Stem Cells Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370